[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA46548A - Fsh pour le traitement de l'infertilité - Google Patents

Fsh pour le traitement de l'infertilité

Info

Publication number
MA46548A
MA46548A MA046548A MA46548A MA46548A MA 46548 A MA46548 A MA 46548A MA 046548 A MA046548 A MA 046548A MA 46548 A MA46548 A MA 46548A MA 46548 A MA46548 A MA 46548A
Authority
MA
Morocco
Prior art keywords
fsh
infertility treatment
infertility
treatment
relates
Prior art date
Application number
MA046548A
Other languages
English (en)
Other versions
MA46548B1 (fr
Inventor
Saez Joan Carlos Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MA46548A publication Critical patent/MA46548A/fr
Publication of MA46548B1 publication Critical patent/MA46548B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des préparations contenant de la fsh, par exemple de la fsh recombinante, pouvant être utilisées dans le traitement de l'infertilité.
MA46548A 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité MA46548B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15164043 2015-04-17
PCT/EP2016/058358 WO2016166288A1 (fr) 2015-04-17 2016-04-15 Composition pour le traitement de l'infertilité
EP16719315.0A EP3283097B1 (fr) 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité

Publications (2)

Publication Number Publication Date
MA46548A true MA46548A (fr) 2018-02-21
MA46548B1 MA46548B1 (fr) 2020-03-31

Family

ID=52997893

Family Applications (1)

Application Number Title Priority Date Filing Date
MA46548A MA46548B1 (fr) 2015-04-17 2016-04-15 Fsh pour le traitement de l'infertilité

Country Status (17)

Country Link
US (3) US10660938B2 (fr)
EP (2) EP3662925B1 (fr)
JP (2) JP7079094B2 (fr)
KR (2) KR20170137041A (fr)
CN (1) CN107405385A (fr)
AU (1) AU2016247498B2 (fr)
CA (1) CA2975444A1 (fr)
DK (2) DK3283097T3 (fr)
ES (2) ES2784625T3 (fr)
HU (2) HUE054300T2 (fr)
MA (1) MA46548B1 (fr)
MX (1) MX2017010883A (fr)
PL (2) PL3662925T3 (fr)
PT (2) PT3662925T (fr)
RU (1) RU2704252C2 (fr)
SI (2) SI3283097T1 (fr)
WO (1) WO2016166288A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107429237B (zh) * 2014-12-22 2021-09-28 豪夫迈·罗氏有限公司 Cmp依赖性的唾液酸酶活性
PL3662925T3 (pl) 2015-04-17 2021-10-25 Ferring B.V. Kompozycja zawierająca FSH do leczenia niepłodności
AR112541A1 (es) * 2017-09-01 2019-11-06 Ferring Bv Composición para estimulación ovárica controlada con hef recombinante
US20210038694A1 (en) * 2018-04-30 2021-02-11 Ferring B.V. Composition for controlled ovarian stimulation
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) * 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228973B (de) * 1961-05-13 1966-11-17 Skf Kugellagerfabriken Gmbh Streckwerk fuer Spinnereimaschinen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
PL3662925T3 (pl) 2015-04-17 2021-10-25 Ferring B.V. Kompozycja zawierająca FSH do leczenia niepłodności

Also Published As

Publication number Publication date
SI3283097T1 (sl) 2020-06-30
KR20170137041A (ko) 2017-12-12
RU2704252C2 (ru) 2019-10-25
KR20240073153A (ko) 2024-05-24
ES2784625T3 (es) 2020-09-29
US20230139407A1 (en) 2023-05-04
HUE048757T2 (hu) 2020-08-28
HUE054300T2 (hu) 2021-08-30
EP3662925B1 (fr) 2021-04-07
CN107405385A (zh) 2017-11-28
WO2016166288A1 (fr) 2016-10-20
AU2016247498A1 (en) 2017-08-17
AU2016247498B2 (en) 2021-06-03
RU2017128296A3 (fr) 2019-06-25
DK3283097T3 (da) 2020-04-20
CA2975444A1 (fr) 2016-10-20
US20180125942A1 (en) 2018-05-10
JP2018513161A (ja) 2018-05-24
PL3662925T3 (pl) 2021-10-25
JP7079094B2 (ja) 2022-06-01
RU2017128296A (ru) 2019-05-17
DK3662925T3 (da) 2021-06-28
EP3662925A1 (fr) 2020-06-10
MX2017010883A (es) 2017-12-07
PT3283097T (pt) 2020-04-06
JP7161511B2 (ja) 2022-10-26
JP2021020915A (ja) 2021-02-18
US10660938B2 (en) 2020-05-26
EP3283097A1 (fr) 2018-02-21
US20200353053A1 (en) 2020-11-12
EP3283097B1 (fr) 2020-02-12
US11439686B2 (en) 2022-09-13
SI3662925T1 (sl) 2021-08-31
PT3662925T (pt) 2021-07-01
PL3283097T3 (pl) 2020-10-19
MA46548B1 (fr) 2020-03-31
ES2879838T3 (es) 2021-11-23

Similar Documents

Publication Publication Date Title
MA46548B1 (fr) Fsh pour le traitement de l'infertilité
MA41013B1 (fr) Compositions comprenant des souches bactériennes
EA201990043A1 (ru) Антибактериальные соединения
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
EA201890204A1 (ru) Антибактериальные соединения
EA201892123A1 (ru) 6-гидрокси-4-оксо-1,4-дигидропиримидин-5-карбоксамиды в качестве агонистов apj
MA42471A (fr) Compositions comprenant des souches bactériennes
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
GEP20207151B (en) Agents, Uses and Methods for the Treatment of Synucleinopathy
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA41977B1 (fr) Imidazopyrazinones utilisées comme inhibiteurs de pde1
MA55434A (fr) Compositions comprenant des souches bactériennes
EA201891344A1 (ru) Новые агонисты рецептора апелина и способы применения
EA201890858A1 (ru) 2,4-дигидроксиникотинамиды как агонисты apj
EA201891336A1 (ru) Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj
PE20180189A1 (es) Composiciones y metodos para el tratamiento de la anemia
MA41758B1 (fr) Procédés de traitement de l'infertilité
TR201902741T4 (tr) Kişisel Temizlik Bileşimleri
MA52920B1 (fr) Compositions et procédés se rapportant à des agonistes de pyridinoylpipéridine 5-ht1f
MA39076A1 (fr) Dérivé de chromone en tant qu'antagoniste dopaminergique d3 pour son utilisation pour le traitement d'un trouble du spectre autistique
MA39837B1 (fr) Quinazoline-thf-amines halogénées en tant qu'inhibiteurs de la pde1
EA201792124A1 (ru) Биотин для лечения амиотрофического латерального склероза
EA202090945A1 (ru) Анти-msln-антитело и фармацевтическая композиция для лечения онкологических заболеваний, содержащая его
FR3070263B1 (fr) Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite
MA40844A (fr) Compositions pharmaceutiques à action prolongée pour l'hépatite c